CorMedix Inc.

1. 01

   Below its 50- and 200-day averages

   The 5 Nov 2026 close of $5.23 was 30.9% below its 50-day average ($7.57) and 31.6% below its 200-day average ($7.64). It has closed below the 200-day for 6 sessions, since 29 Oct 2026. The 50-day average crossed below the 200-day on 4 Nov 2026, 1 session ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 5 Nov 2026

2. 02

   Set a 52-week low on 5 Nov 2026

   Closed at $5.23 on 5 Nov 2026: 59.8% below the 52-week high of $13.02 (30 Dec 2025) and 0.4% above the low of $5.21 (5 Nov 2026).

   Daily price bars, split-adjusted · as of 5 Nov 2026

3. 03

   Behind SPY and its sector fund XLV over 1 year

   1 month: −28.2% (SPY −5.7%, XLV +9.5%). 3 months: −30.4% (SPY −4.6%, XLV +12.4%). 1 year: −53.1% (SPY +8.2%, XLV +26.9%). Price change to the 5 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: CRMD, SPY and XLV · as of 5 Nov 2026

4. 04

   12.7 days to cover short interest

   14.7M shares were sold short at the 15 Oct 2026 settlement, 18.8% of the 77.9M shares outstanding; covering them would take 12.7 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

5. 05

   Volume 2.6× its 30-session average on 2 Nov 2026

   2 Nov 2026 volume of 3.3M shares was 2.6× the average of the 30 sessions before it (1.3M), as the price fell 5.4%. SPY traded 1.2× its own average that session.

   Daily volume against a 30-session baseline · as of 2 Nov 2026

At the 5 Nov 2026 close